| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |